Pramlintide
Also known as: Symlin, Amylin Analog
Synthetic amylin analog; slows gastric emptying, suppresses glucagon, and promotes satiety. Complements insulin therapy.
- Typical dose
- 15 mcg – 120 mcg
- Frequency
- three times daily
- Route
- Subcutaneous
- Half-life
- 48 minutes
- Routes
- Subcutaneous
- Status
- FDA-approved for T1D and T2D (adjunct to insulin)
Benefits
- Post-meal blood sugar control
- Appetite reduction
- Weight loss alongside insulin
- Glucagon suppression
Dosing
A common research range for Pramlintide is 15 mcg to 120 mcg three times daily. Inject before meals; titrate from 15mcg; reduce insulin dose. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Half-life
Pramlintide has an approximate half-life of 48 minutes. Vial can display informational half-life estimates when supported data is available. These estimates are not measured blood concentrations or dosing instructions.
Storage
2-8°C; room temp up to 30 days after opening.
Reported side effects
- Nausea (common initially)
- Hypoglycemia (with insulin)
- Headache
- Anorexia
Contraindications
- Hypoglycemia unawareness
- Gastroparesis
Track Pramlintide with Vial
Vial logs every Pramlintide dose, organizes your schedule, and offers reconstitution math and supported half-life estimates. Tracking records stay on your device. A Vial Pro subscription is required. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. Pramlintide is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.